Table 1: Blood, proteins, glucose testing in P-series patient urine samples using urine test strips.

Parameters and diluted urine samples

Pre-RP urine samples

Post-RP urine samples

Control Um

P2:Ui

P5:Ui

P6:Ui

P8:Ui

P9:Ui

P:Um

P2:Ui

P5:Ui

P6:Ui

P8:Ui

P9:Ui

P:Um

pre-TUR:
Um*

Cancer

pros.

pros.

pros.

pros.

pros.

pros.

blad.

Stage

5Ⅱ

5Ⅰ

Gleason score / Grade

9

7

6

7

7

7.2

3H+2L

Age

77

70

62

63

69

62–77

69–91

Gender

Sampling (5 days)

(-41)–
(-1)

(-34)–
(-1)

(-30)–
(-1)

(-30)–
(-1)

(-27)–
(-1)

(-41)–
(-1)

1–22

1–29

1–33

1–26

1–22

1–33

(-53)–
(-1)

Haemoglobin (mg/dℓ)

stock Ui/Um

1.00

1.40

0.00

0.00

0.00

0.50

0.02

0.15

0.00

0.00

0.01

0.02

0.13

10-1-diluted Ui/Um

0.10

0.15

0.00

0.00

0.00

0.10

0.00

0.02

0.00

0.00

0.00

0.00

0.00

10-2-diluted Ui/Um

0.00

0.04

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

10-3-diluted Ui/Um

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

Dilution for equi-occult blood of 0.01 mg/dℓ or less Hb

Extra-dilution rate

100

140

1

1

1

50

2

15

1

1

1

2

13

Protein (mg/dℓ)

stock Ui/Um

15.0

50.0

50.0

15.0

0.0

30.0

0.0

15.0

50.0

0.0

15.0

15.0

7.5

10-1-diluted Ui/Um

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

10-2-diluted Ui/Um

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

10-3-diluted Ui/Um

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Glucose (mg/dℓ)

stock Ui/Um

0

0

0

0

0

0

0

200

0

0

0

30

50

10-1-diluted Ui/Um

0

0

0

0

0

0

0

0

0

0

0

0

0

10-2-diluted Ui/Um

0

0

0

0

0

0

0

0

0

0

0

0

0

10-3-diluted Ui/Um

0

0

0

0

0

0

0

0

0

0

0

0

0

Pros.: Prostate; pre-TUR: pre-Transurethral Resection; Blad.: Bladder; Hb: Haemoglobin.

Individual patient urine mixture (Ui) of equal volumes of five urine samples from each patient with prostate cancer. P-series urine mixture (P:Um) of equal volumes of 25 urine samples from five patient P2, P5, P6, P8, and P9 on five different days for each pre- and post-radical prostatectomy (post-RP). Ranges of patient 1st–5th sampling days are shown, when day 0 is the ablative operation day of the patient. *Previously prepared and reported sample [11].